What is the recommended dosage of cefdinir (antibiotic) for treating sinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Cefdinir for Sinusitis

For sinusitis treatment, cefdinir should be administered at a dose of 300 mg twice daily or 600 mg once daily for 10 days in adults, and 14 mg/kg once daily for 10 days in children. 1

Adult Dosing

  • Cefdinir can be administered as 300 mg twice daily or 600 mg once daily for 10 days for acute maxillary sinusitis 2, 1
  • Once-daily dosing (600 mg) has been shown to be as effective as twice-daily dosing (300 mg) for sinusitis treatment 1, 3
  • Cefdinir can be taken without regard to meals, improving convenience and adherence 1

Pediatric Dosing

  • For children aged 6 months through 12 years, the recommended dosage for acute maxillary sinusitis is 14 mg/kg once daily or 7 mg/kg twice daily 1
  • The total daily dose should not exceed 600 mg per day 1
  • Treatment duration for pediatric sinusitis should be 10 days 1

Clinical Efficacy

  • Cefdinir has good in vitro activity against common respiratory pathogens including Haemophilus influenzae, Moraxella catarrhalis, and penicillin-susceptible Streptococcus pneumoniae 4
  • Clinical studies have demonstrated that cefdinir is as effective as other recommended antibiotics for sinusitis, including amoxicillin/clavulanate and levofloxacin 5, 3
  • In a multicenter, randomized, double-blind study, cefdinir 600 mg once daily for 10 days showed clinical cure rates of 83%, comparable to levofloxacin's 86% 3

Special Populations

  • For adult patients with creatinine clearance <30 mL/min, the dose should be reduced to 300 mg once daily 1
  • For pediatric patients with creatinine clearance <30 mL/min/1.73 m², the dose should be reduced to 7 mg/kg (up to 300 mg) once daily 1
  • For patients on hemodialysis, an initial dose of 300 mg or 7 mg/kg should be given, followed by 300 mg or 7 mg/kg after each hemodialysis session 1

Advantages of Cefdinir

  • Cefdinir is stable to hydrolysis by commonly occurring plasmid-mediated beta-lactamases, making it effective against beta-lactamase-producing strains of H. influenzae and M. catarrhalis 4
  • It distributes well into respiratory tissues and fluids, including sinus tissue 4, 6
  • The oral suspension has superior taste compared to other antibiotics, improving adherence especially in pediatric patients 4, 6

Common Pitfalls and Considerations

  • Cefdinir may cause diarrhea more frequently than some other antibiotics, though discontinuation rates due to adverse events are generally similar to comparators 4, 3
  • Vaginal moniliasis has been reported in 11% of women taking cefdinir compared to 0% with levofloxacin (p=0.003) 3
  • If there is no clinical improvement within 3-5 days of initiating therapy, consider switching to an alternative antibiotic 2
  • First-generation cephalosporins (like cephalexin) and some second-generation cephalosporins (like cefaclor) have poor activity against H. influenzae and should not be used for sinusitis 2

Alternative Options

  • For patients with penicillin allergy, cefdinir is a suitable alternative 2
  • In cases of treatment failure with amoxicillin, cefdinir is an appropriate second-line option 2, 7
  • Fluoroquinolones should be reserved for situations with high risk of complications or failure of first-line therapy 7, 8

Cefdinir represents an important treatment option for sinusitis, particularly in areas with elevated rates of beta-lactamase production in common respiratory pathogens 6.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.